A detailed history of Lindbrook Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,300 shares of TEVA stock, worth $23,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,300
Previous 981 32.52%
Holding current value
$23,231
Previous $13,000 61.54%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$12.78 - $17.4 $4,076 - $5,550
319 Added 32.52%
1,300 $21,000
Q4 2023

Jan 31, 2024

BUY
$8.12 - $10.63 $2,858 - $3,741
352 Added 55.96%
981 $10,000
Q2 2023

Jul 28, 2023

SELL
$7.2 - $9.47 $1,130 - $1,486
-157 Reduced 19.97%
629 $4,000
Q4 2022

Jan 24, 2023

SELL
$7.95 - $9.48 $524 - $625
-66 Reduced 7.75%
786 $0
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $205 - $358
30 Added 3.65%
852 $7,000
Q2 2022

Aug 01, 2022

SELL
$7.38 - $10.4 $686 - $967
-93 Reduced 10.16%
822 $6,000
Q1 2022

Apr 21, 2022

SELL
$7.33 - $9.39 $2,690 - $3,446
-367 Reduced 28.63%
915 $9,000
Q4 2021

Jan 18, 2022

BUY
$7.9 - $10.19 $6,327 - $8,162
801 Added 166.53%
1,282 $10,000
Q4 2020

Jan 27, 2021

SELL
$8.61 - $11.04 $5,889 - $7,551
-684 Reduced 58.71%
481 $5,000
Q3 2020

Nov 03, 2020

SELL
$8.57 - $12.69 $8,364 - $12,385
-976 Reduced 45.59%
1,165 $10,000
Q2 2020

Jul 27, 2020

BUY
$8.12 - $13.12 $13,154 - $21,254
1,620 Added 310.94%
2,141 $26,000
Q1 2020

Apr 22, 2020

SELL
$6.69 - $13.45 $8,175 - $16,435
-1,222 Reduced 70.11%
521 $5,000
Q4 2019

Jan 27, 2020

SELL
$6.53 - $10.72 $17,748 - $29,136
-2,718 Reduced 60.93%
1,743 $17,000
Q3 2019

Oct 31, 2019

BUY
$6.16 - $9.6 $11,919 - $18,576
1,935 Added 76.6%
4,461 $31,000
Q2 2019

Jul 24, 2019

BUY
$8.12 - $15.72 $300 - $581
37 Added 1.49%
2,526 $23,000
Q1 2019

Apr 23, 2019

BUY
$15.58 - $20.01 $14,723 - $18,909
945 Added 61.2%
2,489 $39,000
Q4 2018

Feb 07, 2019

BUY
$14.59 - $23.84 $22,526 - $36,808
1,544 New
1,544 $23,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.